Kolexia
Macchi Laurent
Biologie médicale
Hôpital La Miletrie
Poitiers, France
56 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lésion d'ischémie-reperfusion Ischémie Hémophilie A Lésion de reperfusion myocardique Troubles hémorragiques Inflammation Ischémie myocardique Maladies rares Infarctus du myocarde

Industries

Bayer
3 collaboration(s)
Dernière en 2022
Sobi
2 collaboration(s)
Dernière en 2021
Sanofi
1 collaboration(s)
Dernière en 2022
Octapharma
1 collaboration(s)
Dernière en 2021

Dernières activités

Tissue Injury Protection: The Other Face of Anticoagulant Treatments in the Context of Ischemia and Reperfusion Injury with a Focus on Transplantation.
International journal of molecular sciences   14 décembre 2023
Point-of-care testing for D-dimer in the exclusion of venous thromboembolism: a critical analysis.
Annales de biologie clinique   29 novembre 2023
Study of the Role of the Tyrosine Kinase Receptor MerTK in the Development of Kidney Ischemia-Reperfusion Injury in RCS Rats.
International journal of molecular sciences   09 novembre 2021
Direct Rivaroxaban-Induced Factor XA Inhibition Proves to be Cardioprotective in Rats.
Shock (Augusta, Ga.)   01 juin 2021
Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study.
Haemophilia : the official journal of the World Federation of Hemophilia   25 août 2020
Remote Ischemic Conditioning in a Model of Severe Renal Ischemia-Reperfusion Injury.
Shock (Augusta, Ga.)   25 juin 2020
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature.
Thrombosis and haemostasis   22 juin 2020
Assessment of conversational pragmatics: A screening tool for pragmatic language impairment in a control population of children aged 6-12 years.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   04 avril 2019
Rivaroxaban, a direct inhibitor of factor Xa, attenuates myocardial ischemia-reperfusion injury in rats at therapeutic concentrations
Archives of Cardiovascular Diseases Supplements   01 avril 2018
ECHANGE:
Essai Clinique (CHU Brest)   27 novembre 2017